Aflac (NYSE:AFL) PT Raised to $84.00 at Morgan Stanley

Aflac (NYSE:AFLGet Free Report) had its target price increased by analysts at Morgan Stanley from $80.00 to $84.00 in a research note issued on Monday, Benzinga reports. The firm presently has an “equal weight” rating on the financial services provider’s stock. Morgan Stanley’s price target suggests a potential upside of 4.05% from the stock’s previous close.

A number of other equities analysts have also issued reports on the company. Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and raised their target price for the stock from $76.00 to $78.00 in a research note on Thursday, January 4th. Raymond James raised their target price on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. Wells Fargo & Company lowered their price objective on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a report on Thursday. The Goldman Sachs Group lifted their price target on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research report on Tuesday, January 9th. Finally, StockNews.com lowered shares of Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, Aflac has an average rating of “Hold” and an average price target of $82.15.

Check Out Our Latest Analysis on Aflac

Aflac Stock Up 0.6 %

NYSE AFL traded up $0.45 during midday trading on Monday, hitting $80.73. 684,620 shares of the company traded hands, compared to its average volume of 2,220,076. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. The company has a market cap of $46.45 billion, a PE ratio of 10.41, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The company’s 50-day simple moving average is $81.88 and its 200-day simple moving average is $81.42. Aflac has a 52 week low of $64.10 and a 52 week high of $86.26.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The business had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $4.44 billion. During the same quarter in the prior year, the company posted $1.29 EPS. As a group, equities research analysts forecast that Aflac will post 6.41 earnings per share for the current year.

Insider Buying and Selling at Aflac

In other Aflac news, SVP Albert Riggieri sold 8,000 shares of the company’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the transaction, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the transaction, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock worth $3,765,706 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Panagora Asset Management Inc. grew its position in shares of Aflac by 36.2% in the first quarter. Panagora Asset Management Inc. now owns 23,941 shares of the financial services provider’s stock valued at $1,542,000 after purchasing an additional 6,369 shares during the last quarter. Blair William & Co. IL boosted its position in Aflac by 6.8% during the first quarter. Blair William & Co. IL now owns 17,268 shares of the financial services provider’s stock worth $1,112,000 after acquiring an additional 1,102 shares during the last quarter. Aviva PLC boosted its position in Aflac by 0.7% during the first quarter. Aviva PLC now owns 210,634 shares of the financial services provider’s stock worth $13,563,000 after acquiring an additional 1,503 shares during the last quarter. Dakota Wealth Management acquired a new stake in Aflac during the first quarter worth approximately $428,000. Finally, Sequoia Financial Advisors LLC boosted its position in Aflac by 7.3% during the first quarter. Sequoia Financial Advisors LLC now owns 6,142 shares of the financial services provider’s stock worth $396,000 after acquiring an additional 417 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Company Profile

(Get Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Analyst Recommendations for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.